Leukapheresis Guidelines and Tisagenlecleucel Manufacturing in Patients Less Than 3 Years of Age with Relapsed/Refractory Acute Lymphoblastic Leukemia

Lamis Eldjerou

American Society of Gene & Cell Therapy Annual Meeting 2020

The presentation that you are looking for is no longer available on this site. Please contact Novartis Oncology Medical Information at 1-844-ONC-INFO (1-844-662-4636).